Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/61828
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Multiple myeloma treatment strategies with novel agents in 2011: A European perspective |
Autor: | Ludwig, Heinz; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID | Fecha de publicación: | 2011 | Editor: | AlphaMed Press | Citación: | Oncologist 16(4): 388-403 (2011) | Resumen: | The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with data to make evidence-based decisions regarding the optimal management of patients. This review is an update to a previous summary of European treatment practices that examines new data that have been published or presented at congresses up to the end of 2010 and assesses their impact on treatment practices. © AlphaMed Press. | URI: | http://hdl.handle.net/10261/61828 | DOI: | 10.1634/theoncologist.2010-0386 | Identificadores: | doi: 10.1634/theoncologist.2010-0386 issn: 1083-7159 e-issn: 1549-490X |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
8
checked on 16-abr-2024
SCOPUSTM
Citations
32
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
20
checked on 29-feb-2024
Page view(s)
272
checked on 17-abr-2024
Download(s)
87
checked on 17-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.